Linked Life Data

6996986

Source:http://linkedlifedata.com/resource/pubmed/id/6996986

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
26
pubmed:dateCreated
1980-11-20
pubmed:abstractText
Sixteen patients with chronic hypertension (grade I-II WHO classification) who had been successfully treated with clonidine (Catapresan Depot Perlongetten), received a placebo capsule on the second, third or fourth day of a five-day trial period. The placebo day was chosen at random. During the test period blood pressure and heart rate were measured daily once by the doctor and three times by the patient himself. There were no demonstrable changes in blood pressure or heart rate either on the placebo day or on the day after which exceeded the chance variations on the other three trial days. None of the patients had withdrawal symptoms.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0012-0472
pubmed:author
pubmed:issnType
Print
pubmed:day
27
pubmed:volume
105
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
928-30
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
1980
pubmed:articleTitle
[Duration of effectiveness of clonidine-depot: a double-blind trial (author's transl)].
pubmed:publicationType
Journal Article, Clinical Trial, English Abstract, Randomized Controlled Trial